Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 6.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 271,219
  • Market Cap: £29.50m
  • RiskGrade: 348

Regulatory News

Holding(s) in Company 27-Nov-2025 14:39 RNS
Holding(s) in Company 25-Nov-2025 15:44 RNS
Plan to Implement ADS Ratio Change 25-Nov-2025 07:00 RNS
Pivotal kidneyintelX.dkd data published 12-Nov-2025 07:00 RNS
Holding(s) in Company 05-Nov-2025 16:02 RNS
Publication of Annual Report & Notice of AGM 04-Nov-2025 18:05 RNS
Holding(s) in Company 03-Nov-2025 12:05 RNS
Audited Full Year Fiscal 2025 Results 03-Nov-2025 07:00 RNS
Holding(s) in Company 30-Oct-2025 16:58 RNS
Holding(s) in Company 28-Oct-2025 16:04 RNS
Confirmation of receipt of £860k R&D tax cr... 27-Oct-2025 07:00 RNS
Holding(s) in Company 24-Oct-2025 10:12 RNS
Holding(s) in Company 23-Oct-2025 09:09 RNS
Holding(s) in Company 21-Oct-2025 10:08 RNS
Holding(s) in Company 17-Oct-2025 10:26 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 6.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.50
52 Week Low 5.62
Volume 271,219
Shares Issued 437.02m
Market Cap £29.50m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 05-Dec-2025

Time Volume / Share Price
16:40 50,000 @ 6.74p
15:26 94 @ 7.00p
12:14 5,000 @ 6.63p
12:13 42 @ 7.00p
10:33 136 @ 6.63p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page